GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaResearch Co Ltd (XKRX:214450) » Definitions » 5-Year Yield-on-Cost %

PharmaResearch Co (XKRX:214450) 5-Year Yield-on-Cost % : 2.26 (As of May. 22, 2024)


View and export this data going back to 2015. Start your Free Trial

What is PharmaResearch Co 5-Year Yield-on-Cost %?

PharmaResearch Co's yield on cost for the quarter that ended in Mar. 2024 was 2.26.


The historical rank and industry rank for PharmaResearch Co's 5-Year Yield-on-Cost % or its related term are showing as below:

XKRX:214450' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.79   Med: 2.29   Max: 3.51
Current: 2.26


During the past 10 years, PharmaResearch Co's highest Yield on Cost was 3.51. The lowest was 0.79. And the median was 2.29.


XKRX:214450's 5-Year Yield-on-Cost % is ranked better than
59.87% of 152 companies
in the Biotechnology industry
Industry Median: 1.615 vs XKRX:214450: 2.26

Competitive Comparison of PharmaResearch Co's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, PharmaResearch Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaResearch Co's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaResearch Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where PharmaResearch Co's 5-Year Yield-on-Cost % falls into.



PharmaResearch Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of PharmaResearch Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

PharmaResearch Co  (XKRX:214450) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


PharmaResearch Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of PharmaResearch Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaResearch Co (XKRX:214450) Business Description

Traded in Other Exchanges
N/A
Address
74 Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Seongnam, KOR, 463-400
PharmaResearch Co Ltd formerly Pharma Research Products Co Ltd is a bio pharmaceutical firm which realizes a new treatment paradigm for regenerative medicine. Its products include Rejuran, Rejuvenex, and Re-An eye drops. It also provides medical devices, cosme ceuticals, and dietary supplements.

PharmaResearch Co (XKRX:214450) Headlines

No Headlines